EWTX
Edgewise Therapeutics Inc

539
Loading...
Loading...
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
110

Frequently Asked Questions

What is Market Cap of Edgewise Therapeutics Inc?
What is the 52-week high for Edgewise Therapeutics Inc?
What is the 52-week low for Edgewise Therapeutics Inc?
What is Edgewise Therapeutics Inc stock price today?
What was Edgewise Therapeutics Inc stock price yesterday?
What is the PE ratio of Edgewise Therapeutics Inc?
What is the Price-to-Book ratio of Edgewise Therapeutics Inc?
What is the 50-day moving average of Edgewise Therapeutics Inc?
How many employess does Edgewise Therapeutics Inc has?

Latest EWTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.